Tormod Fladby

Tormod Fladby serves as an Adjunct Professor at the University of Oslo, with primary clinical and research affiliation at Akershus University Hospital's Division of Medicine and Laboratory Sciences. His work bridges clinical neurology and dementia research, focusing on practical applications of biomarker science for improved diagnosis and monitoring of neurodegenerative conditions.

Dr. Fladby's research program encompasses several critical areas in cognitive disorders:

• Development and validation of blood-based biomarkers for Alzheimer's disease, particularly phosphorylated tau (p-tau217)
• Establishment of Norwegian normative data for neuropsychological tests including D-KEFS and Rey Auditory Verbal Learning Test
• Investigation of relationships between amyloid pathology, tau pathology, neuroinflammation, and cognitive outcomes
• Studies on cognitive recovery following stroke and rehabilitation
• Examination of sex differences in neurodegenerative processes and biomarker expression

His recent publications reveal a strong trend toward precision medicine applications in dementia diagnosis, with particular emphasis on making biomarker testing more accessible through blood-based methods. Significant work focuses on culturally appropriate cognitive assessment tools for Scandinavian populations, addressing a critical gap in dementia diagnosis. His research consistently examines how different pathological processes interact to produce cognitive symptoms, with implications for both diagnosis and treatment.

Dr. Fladby actively collaborates with the Clinical Neuroscience Group at Akershus University Hospital, working within a multidisciplinary team that includes neurologists, neuropsychologists, and laboratory scientists. His work has direct clinical relevance for improving diagnostic accuracy in memory clinics and developing more effective monitoring strategies for patients with cognitive disorders.